Primexpharma
1 known investors
Find your way into Primexpharma
120 people in our graph share verified history with the Primexpharma team — schools, employers, funds. One of them is your warm intro.
Michal Lasockiunlockedknows Jany Mengelkamp · together at Maastricht University (overlapped)
×11knows the team · via Maastricht University
Primex Pharmaceuticals owns and markets specialty anaesthetic pharmaceuticals for perioperative therapy on a global basis. The company acquires rights to established drug candidates and manages regulatory affairs and distribution without conducting internal R&D or manufacturing.
Founders & leadership
JM

Jany MengelkampBoard Member & Co-FounderJany Mengelkamp is board member and co-founder of Primex Pharmaceuticals, which acquires and markets specialty anesthetic drugs for perioperative use globally. He brings experience from the pharmaceutical and management consulting sectors, with expertise in business development and international business strategy.
Investors · 1
Frequently asked questions
- What does Primexpharma do?
- Primex Pharmaceuticals owns and markets specialty anaesthetic pharmaceuticals for perioperative therapy on a global basis. The company acquires rights to established drug candidates and manages regulatory affairs and distribution without conducting internal R&D or manufacturing.
- Who founded Primexpharma?
- Primexpharma was founded by Jany Mengelkamp.
- Who are Primexpharma's investors?
- Primexpharma's investors include Innovestor Ventures.
